REQUEST A DEMO
Total
USD $0.00
Search more companies

Bavet Ilac A.S. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Bavet Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: March 05, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Bavet Ilac A.S. is a company based in Turkiye, with its head office in Istanbul. It operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on June 13, 2000. There are currently 40 (2025) people employed by Bavet Ilac A.S.. There was a net sales revenue increase of 109.92% reported in Bavet Ilac A.S.’s latest financial highlights for 2024. A growth of 64.76% was recorded in its total assets.

Headquarters
Tuzla Organize Sanayi Bolgesi No:8 Ist.tuzla Org.san.bolg.12.caddesi Tuzla
Istanbul; Marmara; Postal Code: 34940

Contact Details: Purchase the Bavet Ilac A.S. report to view the information.

Website: http://www.bavet.com.tr

Basic Information
Total Employees:
Purchase the Bavet Ilac A.S. report to view the information.
Financial Auditors:
Purchase the Bavet Ilac A.S. report to view the information.
Incorporation Date:
June 13, 2000
Key Executives
Purchase this report to view the information.
Vice Chariman
Company Performance
Financial values in the chart are available after Bavet Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
109.92%
Total Operating Revenue
109.92%
Operating Profit
168.12%
Net Profit/Loss for the Period
N/A
Total Assets
64.76%
Total Equity
27.81%
Operating Profit Margin
10.18%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
33.5%
Quick Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?